{"retracted":false,"update":{"timestamp":1396310400000,"doi":"10.1016/j.bmcl.2014.02.050","type":"err"},"doi":"10.1016/j.bmcl.2012.03.070","journal":"Bioorganic & Medicinal Chemistry Letters","publisher":"Elsevier BV","title":"Corrigendum to “Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities” [Bioorg. Med. Chem. Lett. 22 (2012), 3067–3071]"}
